Citadel Advisors’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-36,400
Closed -$1.69M 10190
2018
Q3
$1.69M Buy
36,400
+20,900
+135% +$1.01M ﹤0.01% 4671
2018
Q2
$748K Buy
15,500
+1,900
+14% +$90.9K ﹤0.01% 5716
2018
Q1
$589K Buy
13,600
+1,900
+16% +$85.3K ﹤0.01% 5622
2017
Q4
$464K Sell
11,700
-13,100
-53% -$546K ﹤0.01% 5769
2017
Q3
$1.08M Sell
24,800
-85,200
-77% -$3.89M ﹤0.01% 4209
2017
Q2
$5.26M Buy
110,000
+101,100
+1,136% +$4.72M ﹤0.01% 2071
2017
Q1
$365K Sell
8,900
-15,900
-64% -$664K ﹤0.01% 5571
2016
Q4
$952K Sell
24,800
-15,600
-39% -$633K ﹤0.01% 3925
2016
Q3
$2.17M Buy
40,400
+23,900
+145% +$1.11M ﹤0.01% 2879
2016
Q2
$710K Sell
16,500
-12,500
-43% -$525K ﹤0.01% 4010
2016
Q1
$1.47M Buy
29,000
+13,800
+91% +$664K ﹤0.01% 3020
2015
Q4
$962K Sell
15,200
-16,100
-51% -$1.1M ﹤0.01% 3630
2015
Q3
$2.05M Buy
31,300
+22,300
+248% +$1.48M ﹤0.01% 2910
2015
Q2
$609K Sell
9,000
-9,200
-51% -$508K ﹤0.01% 4674
2015
Q1
$777K Sell
18,200
-7,800
-30% -$347K ﹤0.01% 4280
2014
Q4
$1.28M Buy
26,000
+8,700
+50% +$348K ﹤0.01% 3433
2014
Q3
$497K Sell
17,300
-13,400
-44% -$364K ﹤0.01% 4635
2014
Q2
$804K Buy
30,700
+24,500
+395% +$633K ﹤0.01% 3780
2014
Q1
$345K Buy
6,200
+800
+15% +$46K ﹤0.01% 4858
2013
Q4
$260K Buy
+5,400
New +$227K ﹤0.01% 4751

Citadel Advisors's IMPV Position: Q1 2019 in Review

Citadel Advisors sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 23,597 shares — an estimated $1.31M sold.

Citadel Advisors first reported a position in IMPV in Q3 2013 and held it in 22 quarters. The position peaked at $46.8M in Q3 2016. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Citadel Advisors reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Citadel Advisors sold 23,597 Imperva, Inc. shares in Q1 2019, an estimated $1.31M.
  • Citadel Advisors first reported a position in Imperva, Inc. in Q3 2013 and held it in 22 quarters.
  • Citadel Advisors's Imperva, Inc. position peaked at $46.8M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.